MedTrace Logo

Xenograft with or Without Erythropoietin in Immediate Dental Implant

NCT06601400 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of this study is to evaluate changes in buccal bone thickness after immediate implant placement with xenograft mixed with erythropoietin in the anterior maxilla with a thin buccal bone

Conditions

  • Hopeless Teeth

Interventions

COMBINATION_PRODUCT

Erythropoietin (EPO) with xenograft

After atraumatic extraction of the non-restorable tooth, Implant will be placed palatal and apical to osteotomy with at least 2mm gap junction between implant and buccal bone which will be grafted with xenograft and erythropoietin.

OTHER

Xenograft alone

After atraumatic extraction of the non-restorable tooth, implant will be placed palatal and apical to osteotomy with at least 2mm gap junction between implant and buccal bone which will be grafted with xenograft alone.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Noha ghallab, PHD · Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University.

  • Manar El Zanaty, PHD · lecturer of periodontology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-14
Primary Completion
2025-10-31
Completion
2026-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06601400 on ClinicalTrials.gov